Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cofactor Regeneration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzymatic method reduces cost and purification difficulty for sugar nucleotides. Scalable process ensures supply chain reliability for global partners.
Patent CN116287064A enables cost-effective rare sugar nucleotides production via OPME and cofactor regeneration. Ideal for pharmaceutical intermediates manufacturing.
Patent CN114277006A reveals a novel alcohol dehydrogenase for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant supply chain and cost advantages.